期刊文献+

小儿急性淋巴细胞白血病的诊疗浅谈 被引量:2

下载PDF
导出
摘要 急性淋巴细胞白血病 (acutelymphoblasticleukemiaALL)是小儿最常见的恶性肿瘤性疾病。常见的治疗是以化疗为主的综合治疗。近年来 ,免疫、遗传分子生物学在儿童白血病的临床方面的应用 ,对了解小儿ALL的发病机制、改进治疗、判断预后有其十分重要的意义。本文就其小儿ALL的分类。
作者 孙黎明 原弛
机构地区 北京铁路总医院
出处 《中国小儿血液》 2001年第5期235-237,共3页 China Child Blood
  • 相关文献

参考文献13

  • 1左启华等.儿科学.第四版.北京:人民卫生出版社.1993.
  • 2Kaletschll, Kaatsch P, Michaelis J: Jahresbericht 1995 des Deutschen Kinderkrebsregister. Universitat Main 2, 1996.
  • 3Bemet JM, Catosky D, Daniel MT, et al. Proposals for the classification of acute leukemias: Concordance among observers and clinical correlation. Br J Haematol. 1981, 47:553 - 561.
  • 4Bene MC, Castoldi G, Knapp et al. Proposals for the immunological classification of acute Leukemias. European Group for the Immunological charakterrization of Leukemias(EGIL). Leukemia. 1995, 9: 1783-1786.
  • 5Schleiben S, Borkhardt A, Reinisch, et al. Incidence and clinical outcome of children with BCR/ABL - Positive acute lymphoblastic leukemia(ALL). A prospective RT - PCR study based on 673 patients enrolled in the German Pediatric Multicenter therapy trials ALL - BFM - 90 and COALL - 05 - 92.Leukemia. 1996, 10: 957-963.
  • 6Janka GE, Winkler K, Gobel U, et al. Rapidly mutating Combination chemotherapy in childhood acute lymphablastic leukemia: preliminary mesults of a randomired comparison with comentional treatment. Leukemia. 1988, 2: 73 - 78.
  • 7Riehm H, Gadner H, Henze G, et al. Results and Significance of six mandomized trials in four consecutive ALL - BFM trials.Hemalol Blood Transf. 1990, 33:439 - 450.
  • 8Gobel GE, Graubner U. Improved prognosis for childhood acute lymphablastic leukemia (ALL) with very high white blood count( > 100/ul) with roration of non cross - resistant drug combination. Hacmatal Blood Transt. 1990, 33: 489 - 492.
  • 9Richm H. Reiter A, Schrappem, et al, Dic Cocticosteroidabhangige Dezimierug der Leukamiczellzall in Blut als Prognosefactor bei der acute lymphoblastichen Leukemic im Kindesalter(Therapiestudie ALL- BFM- 83). Klin Padiatr. 1987, 199:151 - 160.
  • 10Nachman J, Sather H, Lukens J, et al. Augment BFM(ABFM) for treatment of children and young adults with high risk acute lymphoblastic leukemia (ALL).

同被引文献11

  • 1张艳萍,石太新,唐成和.左旋门冬酰胺酶治疗儿童急性淋巴细胞白血病毒副作用及防治[J].中国煤炭工业医学杂志,2007,10(5):583-584. 被引量:2
  • 2Mitchell GL,Maureen A,Kim H,et al.Trend to deeicacy and sagety using antithrombrombin concentrate in prevention of thrombosisi in children receiving L-asparaginase for acute lymphoblastic leukemia[J].Thromb Haemost,2003,90:235-244
  • 3Andrew M,Brooker L,Mitchell L.Acquired antithrombinⅢdeficiency secondary to asparaginase therapy in childhood acute lymphblastic leukaemia[J].Blood Coagul Fibrinol,1994,5:524-526
  • 4Mitchell GL,the PARKA AGroup.A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with D-asparaginase[J].Cancer,2003,97:508-516
  • 5Wlazlowski M,Celinska W,Maciejka Kapuscinska L,et al.Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase[J].Pol Tyg Lek,1994,49 (12-13):296
  • 6Greenstrein R,Nogeire C,Ohnuma T,et al.Management of Lssparaginase induced hemorrhagic pancreatitis complicated by pseudocyst[J].Cancer,1998,43:718
  • 7Vieira Pinheiro JP,Muller HJ,Schwabe D,et al.Drug monitoring of low-dose PEG-asparaginase in children with relapsed scute lymphoblastic leukemia[J].Br J Haematol,2001,113 (1):115
  • 8苏永华.详解门冬酰胺酶[N].上海中医药报,2012-09-14(004).
  • 9Alberts SR. Bretscher M, Wiltsie JC, et al. Thrombosis related to the use of L- asparaginase in adults with acute lymphoblastic leu- kemia:A need to consider coagulation monitoring and clotting fac tor replacement[J]. Leuk Lymphoma, 1999,32 : 489 - 496.
  • 10高红英,陈娟娟,陈光福.儿童急性淋巴细胞白血病医院感染临床分析[J].临床医药实践,2010,19(8):566-568. 被引量:7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部